8CS-67828-64015
3 vaccinations
2 coded responses
22 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 448 / OH
- Registered
- 2020-12-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Dose 1 — Moderna
-
2020-12-25
Registered in v-safe
- 2020-12-27
- 2020-12-28
- 2020-12-30
- 2020-12-31
-
2021-01-07
Survey response — day 14, dose 1MedDRA: Headache, Oropharyngeal pain, Paranasal sinus discomfort, Upper-airway cough syndrome — Feeling: Fair · Be unable to workFree text: Sore throat, headache, sinus pressure, post nasal dripMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-07
- 2021-01-14
-
2021-01-21
Dose 2 — Moderna
- 2021-01-21
- 2021-01-22
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-30
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-04-22
-
2021-12-01
Dose 3 — Pfizer-BioNTech
- 2022-06-01
-
2022-12-01
Survey response — 12 months, dose 3MedDRA: COVID-19, Pulmonary fibrosis, Pulmonary mass — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid-19 infection in July, pulmonary nodule that is now a scar that required monitoring by CTAMedDRA releases: 2024-11 · check-in free text available
-
2022-12-01
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-12-02
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Moderna | |
| 2 | 2021-01-21 | Moderna | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 14, dose 1
Symptoms: Sore throat, headache, sinus pressure, post nasal drip
Release 12 — 12 months, dose 3
Symptoms: Covid-19 infection in July, pulmonary nodule that is now a scar that required monitoring by CTA
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
| SD | Pulmonary fibrosis | · | · | ✓ |
| SD | Pulmonary mass | · | · | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release